Title: Success is a Great Investment
1Success is a Great Investment
- David Gilbert
- 510.643.5542
- dgilbert_at_uclink.berkeley.edu
- http//ucdiscoverygrant.org
2Adversity draws men together and produces beauty
and harmony in lifes relationships, just as
the cold of winter produces ice-flowers on the
window-panes, which vanish with the warmth.Soren
Kierkegaard (18131855), Danish philosopher.
The Challenge
3Lifeless in appearance, sluggishdazed spring
approaches
- William Carlos Williams (18831963)
4The OpportunitySpring is Upon Us!
- 20 million in matching funds available to seed
for partnerships between UC faculty industry
targeting high risk, early stage research. - Enhance economic competitiveness
- Stimulate growth and investment
- Accelerate delivery of public benefits
5Funding Emerging Technology
Portfolio includes all 10 UC Campuses 3 UC
Managed National Labs
- Biotechnology
- Communications, Networking, Operating Systems
- Digital Media
- Electronics Manufacturing New Materials
- Life Sciences Information Technology
- Microelectronics
6Program Partnership
Matching
Investment
Industry
UC Laboratory
7Rules of Engagement
- Grant funds must be matched at least 11
- 1- to 4-year term
- Yearly investment ranges from 20K to 2M (but
no upper limit) - Up to 30 in-kind contribution allowed 40
under a Major Program Award (multicampus) - Proposals due in Feb, May, and Oct
8Rapid Access to Benefits
- Quick response (100 day turn-around)
- Easy on-line application process
- Peer review/industry validation
9Anatomy of the Process
10Benefits to Industry Sponsor
- Leverage scientific/technical expertise
- Pilot strategic RD direction
- Leverage RD funding
- Access UC facilities/infrastructure
- Exclusive access to intellectual property
11Benefits to UC Researchers
- Access to
- Company know-how
- Expensive equipment/reagents
- Economic information
- Fast-track patent applications
- Student/Post-doc experience with companies
(leading to future jobs)
12 Industry Sponsor Qualifications
- California-based
- Maintains RD or manufacturing facilities in
California related to the proposed research - California Agricultural Market Order Boards
- Not California-based
- Maintains RD alliance with a California company
that is related to the proposed research - Provides strong justification that the research
will demonstrably benefit California agriculture
13Intellectual Property
- UC Title inventions arising from research
conducted under the Research Agreement by UC
scientists at UC facilities - Exclusive License Industry Sponsors granted
option to any patentable inventions conceived and
first reduced to practice in the under the
Research Agreement
14Who Has Participated
15Industry Participants FY 96-02
Employees Companies Sponsors
1-50 209 3351-500 143
22501-1000 33 51001 255
40 Total 640 100
16 UC FacultyAsst. Professors 135
15 Assoc/Full Profs. 678 73DOE/campus
non-faculty 111 12Total 924
100UC StudentsUndergraduate 113
13Graduate 456 53Postdocs 297
34Total 866 100
UC Investigator/Student Impact
17How to Make it Happen
18Strategic Alliances
- Regional Technology Alliances (RTAs)
- CONNECT (UCSD, UCD, UCR)
- California Healthcare Institute (CHI)
- Bio E2E
- BayBio
- BIOCOM
19Portals to Partnership
- The California Institutes for Science
Innovation - QB3 The California Institute for
Bioengineering, Biotechnology Quantitative
Biomedical Research (UCSF, UCB, UCSC) - CAL-(IT)2 The California Institute for
Telecommunications Information Technology
(UCSD, UCI) - CNSI The California Nanosystems Institute (UCLA,
UCSB) - CITRIS The Center for Information Technology
Research in the Interest of Society (UCB, UCD,
UCM, UCSC)
20Selected Funded Biotech Projects
- High-Rate Anaerobic Digestion System for
Biogasification of Organic Wastes - Improved Recombinant Bacterial Insecticides
- Breast Cancer Vaccines from Plants
- Surface Characterization of Novel Biomaterials
- New Non-Fourier Processing Method for NMR
Spectroscopy - Cell-Based Therapeutics Treatment of Parkinsons
Disease - Controlled Differentiation of Pluripotent Stem
Cells - Preventing Telomere Shortening and Replicative
Senescence in HIV-specific T cells - Inhibition of Allergic Responses by Gene
Immunotherapy - Development of Bead-Embedded Technology for
Biochip Fabrication
21Success is a Great Investment
David Gilbert 510.643.5542 dgilbert_at_uclink.berkele
y.edu http//ucdiscoverygrant.org